Adenosine given before artery-opening procedure for heart attack to prevent slow blood flow
Tests adenosine before artery-opening procedures in adults having a serious heart attack.
Plain-language title generated from the registry record
Registry title: Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention
Key facts
- Where
- Karachi, PakistanSee the site
- Phase
- Phase 4
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Source: NCT07536802, who can take part
Where in Pakistan
- National Institute of Cardiovascular DiseasesKarachi, PakistanTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- National Institute of Cardiovascular Diseases, Pakistan
- Trial code
- NCT07536802
- Record updated
- 22 April 2026
- Original description
Primary objective of the study is to evaluate the impact of adenosine pre-medication on incidence of slow flow/no-reflow after primary percutaneous coronary intervention.Read full original descriptionShow less
Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention: A Randomized Control Trial
Primary objective of the study is to evaluate the impact of adenosine pre-medication on incidence of slow flow/no-reflow after primary percutaneous coronary intervention.
Inclusion: All patients with acute STEMI undergoing primary PCI; Patients of either sex, ≥18 years of age.
Exclusion: Patients with heart block; Allergy to adenosine; STEMI patients with cardiogenic shock at presentation; Patients refuse to give consent for participation.